Conference Speakers

Srini Akkaraju, M.D., Ph.D.

Founder & Managing Partner

Samsara BioCapital
Srini Akkaraju, M.D., Ph.D. Founder & Managing Partner Samsara BioCapital

Deborah Baron

Senior Vice President, Worldwide Business Development

Pfizer
Deborah Baron Senior Vice President, Worldwide Business Development Pfizer

Kate Bingham

Managing Partner

SV Health Investors
Kate Bingham Managing Partner SV Health Investors

Paul Biondi

Managing Partner

Flagship Pioneering
Paul Biondi Managing Partner Flagship Pioneering

Jay Bradner, M.D.

Executive Vice President, Research & Development

Amgen
Jay Bradner, M.D. Executive Vice President, Research & Development Amgen

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners
Mira Chaurushiya, Ph.D. Managing Director Westlake Village BioPartners

Benjamin Chen, Ph.D.

Partner

Panacea Venture
Benjamin Chen, Ph.D. Partner Panacea Venture

John Connolly, Ph.D.

Chief Scientific Officer

Parker Institute for Cancer Immunotherapy
John Connolly, Ph.D. Chief Scientific Officer Parker Institute for Cancer Immunotherapy

Ben Cravatt, Ph.D.

Professor & Gilula Chair, Chemical Biology

The Scripps Research Institute
Ben Cravatt, Ph.D. Professor & Gilula Chair, Chemical Biology The Scripps Research Institute

Scott DeWire, Ph.D.

Corporate Senior Vice President, Head of Global BD&L

Boehringer Ingelheim
Scott DeWire, Ph.D. Corporate Senior Vice President, Head of Global BD&L Boehringer Ingelheim

Giulio Draetta, M.D., Ph.D.

Chief Scientific Officer

University of Texas MD Anderson Cancer Center
Giulio Draetta, M.D., Ph.D. Chief Scientific Officer University of Texas MD Anderson Cancer Center

Amy DuRoss

Mayo Venture Partner

Mayo Clinic
Amy DuRoss Mayo Venture Partner Mayo Clinic

Jon Edwards, Ph.D.

Partner

Forbion
Jon Edwards, Ph.D. Partner Forbion

Niels Emmerich, Ph.D.

Vice President, Search and Evaluation & Global Alliances

AbbVie
Niels Emmerich, Ph.D. Vice President, Search and Evaluation & Global Alliances AbbVie

Ramy Farid, Ph.D.

President & CEO

Schrödinger
Ramy Farid, Ph.D. President & CEO Schrödinger

Evan Feinberg, Ph.D.

Founder & CEO

Genesis Molecular AI
Evan Feinberg, Ph.D. Founder & CEO Genesis Molecular AI

Jennifer Giottonini Cayer

Chief Business Officer

Pulmocide
Jennifer Giottonini Cayer Chief Business Officer Pulmocide

Corey Goodman, Ph.D.

Managing Partner

venBio Partners
Corey Goodman, Ph.D. Managing Partner venBio Partners

Jason Hafler, Ph.D.

Managing Director

Sanofi Ventures
Jason Hafler, Ph.D. Managing Director Sanofi Ventures

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures
Richard Heyman, Ph.D. Venture Partner ARCH Ventures

Rachna Khosla

Senior Vice President, Business Development

Amgen
Rachna Khosla Senior Vice President, Business Development Amgen

Nina Kjellson

General Partner

Canaan Partners
Nina Kjellson General Partner Canaan Partners

Daphne Koller, Ph.D.

Founder & CEO

insitro
Daphne Koller, Ph.D. Founder & CEO insitro

Judith Li

Partner

Lilly Asia Ventures
Judith Li Partner Lilly Asia Ventures

Tim Luker, Ph.D.

Vice President, Lilly Ventures, West Coast USA Head, Corp BD

Eli Lilly
Tim Luker, Ph.D. Vice President, Lilly Ventures, West Coast USA Head, Corp BD Eli Lilly

Mathai Mammen, M.D., Ph.D.

Chairman, CEO & President

Parabilis Medicines
Mathai Mammen, M.D., Ph.D. Chairman, CEO & President Parabilis Medicines

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck
Grace Han McMahon AVP and Head, Pacific BD&L Merck

Detlev Mennerich, Ph.D.

Global Head

Boehringer Ingelheim Venture Fund
Detlev Mennerich, Ph.D. Global Head Boehringer Ingelheim Venture Fund

Nikhil Mutyal, Ph.D.

Head of Search & Evaluation, Respiratory & Immunology

AstraZeneca
Nikhil Mutyal, Ph.D. Head of Search & Evaluation, Respiratory & Immunology AstraZeneca

Carolyn Ng, Ph.D.

Partner & Managing Director

TPG Life Sciences Innovations
Carolyn Ng, Ph.D. Partner & Managing Director TPG Life Sciences Innovations

Carole Nuechterlein

Head

Roche Venture Fund
Carole Nuechterlein Head Roche Venture Fund

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative

5AM Ventures
Deborah Palestrant, Ph.D. Partner & Executive Chair, 4:59 Initiative 5AM Ventures

Mark Paris, Ph.D.

Executive Director, Oncology Search and Evaluation

Daiichi Sankyo
Mark Paris, Ph.D. Executive Director, Oncology Search and Evaluation Daiichi Sankyo

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck
Sunil Patel Head of Corporate Development and Business Development & Licensing Merck

Steven Paul, M.D.

Board Chair, FNIH; Venture Partner

Third Rock Ventures
Steven Paul, M.D. Board Chair, FNIH; Venture Partner Third Rock Ventures

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK
Jeremy Quirk VP BD&L Commercial Portfolio GSK

James Schaeffer, Ph.D.

Vice President, Business Strategy

PhenoTarget
James Schaeffer, Ph.D. Vice President, Business Strategy PhenoTarget

Peter Schultz, Ph.D.

President, CEO & Professor of Chemistry

Scripps Research
Peter Schultz, Ph.D. President, CEO & Professor of Chemistry Scripps Research

Tim Scott

President & CEO

Biocom California
Tim Scott President & CEO Biocom California

Jonathon Sedgwick, Ph.D.

Senior Vice Pre​sident & Global Head, Discovery Research

AbbVie
Jonathon Sedgwick, Ph.D. Senior Vice Pre​sident & Global Head, Discovery Research AbbVie

Daniel Skovronsky, M.D., Ph.D.

Chief Scientific & Product Officer; President, Lilly Research Laboratories

Eli Lilly
Daniel Skovronsky, M.D., Ph.D. Chief Scientific & Product Officer; President, Lilly Research Laboratories CSO & President, Lilly Research Laboratories; President, Immunology Eli Lilly

Ken Song, M.D.

Chairman, President & CEO

Candid Therapeutics
Ken Song, M.D. Chairman, President & CEO Candid Therapeutics

Avi Spier, Ph.D.

Executive Director, Search & Evaluation

Novartis
Avi Spier, Ph.D. Executive Director, Search & Evaluation Novartis

Lior Teitelbaum, M.Sc.

Senior Director, Venture Investments

Johnson & Johnson Innovation – JJDC
Lior Teitelbaum, M.Sc. Senior Director, Venture Investments Johnson & Johnson Innovation – JJDC

Marc Tessier-Lavigne, Ph.D.

CEO

Xaira Therapeutics
Marc Tessier-Lavigne, Ph.D. CEO Xaira Therapeutics

Nancy Thornberry

Founding CEO & Chair, R&D

Kallyope
Nancy Thornberry Founding CEO & Chair, R&D Kallyope

Richard Tillyer, Ph.D.

Global Head, Discovery, Product Development & Supply

Johnson & Johnson Innovative Medicine
Richard Tillyer, Ph.D. Global Head, Discovery, Product Development & Supply Johnson & Johnson Innovative Medicine

Issei Tsukamoto, Ph.D.

SVP, Head of Business Development

Astellas Pharma
Issei Tsukamoto, Ph.D. SVP, Head of Business Development Astellas Pharma

D.A. Wallach

Co-Founder & General Partner

Time BioVentures
D.A. Wallach Co-Founder & General Partner Time BioVentures

Chen Yu, M.D.

Founder & Managing Partner

TCGX
Chen Yu, M.D. Founder & Managing Partner TCGX

Su Zhang, Pharm.D.

CEO, Acting CBO for CoDevCo Clients

CoDevCo
Su Zhang, Pharm.D. CEO, Acting CBO for CoDevCo Clients CoDevCo